CVS Denies Aetna Deal Reverses Efforts To Cut Drug Prices

By Christopher Cole · June 20, 2019, 7:39 PM EDT

CVS has told a D.C. federal judge that the drugstore chain's $69 billion megadeal with Aetna won't interfere with its pharmacy benefit manager's push to cut drug prices, despite what groups...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Letter

Case Information

Case Title

UNITED STATES OF AMERICA et al v. CVS HEALTH CORPORATION et al

Case Number

Court

District Of Columbia

Nature of Suit

Anti-Trust

Date Filed

October 10, 2018

Recent Articles By Christopher

November 28, 2023
FCC To Ease Signing-Up For Rural Health Funding Projects
November 28, 2023
Advocates Worry 988 Hotline Georouting Will Get Delayed
September 12, 2023
Lead-Covered Verizon Cables Put Workers At Risk, Suit Says
July 20, 2023
FCC Requires Providers To Report 988 Crisis Line Outages
April 24, 2023
Shentel Fined $227K For 911 Audio Outages
January 26, 2023
FCC Aims To Improve Outage Reporting For 988 Hotline
January 26, 2023
FCC Reworks Payment Model For Rural Health Connectivity
January 20, 2023
FCC Urged To Keep Telehealth Rates' Status Quo For Now
July 27, 2022
House Votes To Extend FCC's Spectrum Auction Powers
April 05, 2022
Windstream To Pay $1.2M In FCC Settlement Over Rural Rates